QUARTERLY IN DEPTH INVESTMENT ANALYSIS – BIOTECH UPDATE (NYSE: CYBN)
I have been watching $CYBN for quite some time and believe that I am starting to get a very good feel for the name, hence why I think the timing is right for another thesis update. Not only do I think that the chart is starting to look really good technically, there is a lot that
Share: